Sanchez, Mark Arvie E.

HRN: 28-27-73  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/16/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/16/2026
01/23/2026
IV
4.5g
Q6hr
CAP-HR
Checking Initial Appropriateness 

 Indication:  Empirical Escalation    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines